Caltag Medsystems – Page 20 – UK distributor of antibodies, enzymes, kits and related products for use in research applications and clinical diagnosis.

Blog

SARS-CoV-2 (COVID-19) Mutations

As viruses create more of themselves, they mutate – single-point changes in genetic code. SARS-CoV-2 virus mutated to be more transmissible.

The cytokine storm is a relatively new discovery & is actively being studied. ProSci offers cytokine & chemokine antibodies & recombinant proteins.

The SARS-CoV-2 genome is ~29 kb divided into 10 ORFs. Each of these ORFs (except seemingly ORF10) is translated in 29 different proteins.

Research continues in understanding mechanisms of SARS-CoV-2 immune evasion. ProSci offers antibodies & recombinant proteins for SARS-CoV-2 research.

When it comes to primary cell culture, a picture is worth a thousand words. Follow these tips from ScienCell to get quality microscopy images.

ProSci has developed SARS-CoV-2 variant-specific reagents by focusing on unique point mutations in the spike protein.

mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.

Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.

CELLvo™ Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes cultured on CELLvo™ Matrix Plus. Achieve maturation in 7 days.

The human leukocyte antigen system, aka human major histocompatibility complex, was named after its discovery with alloantibodies against leukocytes.